We are live on
!
Find out more
ZEAL
Zealand Pharma A/S American Depositary Shares
ZEAL
ZEAL
Delisted
ZEAL was delisted on the 29th of September, 2022.
13 hedge funds and large institutions have $71.7M invested in Zealand Pharma A/S American Depositary Shares in 2019 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 3 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
33% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 3
15% more capital invested
Capital invested by funds: $62.2M → $71.7M (+$9.45M)
0% more funds holding
Funds holding: 13 → 13 (0)
0% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 2
Holders
13
Holders Change
–
Holders Change %
0%
% of All Funds
0.29%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
4
Reduced
3
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Jane Street
New York
|
+$270K |
| 2 |
Renaissance Technologies
New York
|
+$240K |
| 3 |
FCM
Farallon Capital Management
San Francisco,
California
|
+$226K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$173K |
| 5 |
Morgan Stanley
New York
|
+$40.4K |
